Neurocognition as a major predictor of 8-week response to antipsychotics for drug-naïve first-episode schizophrenia using machine learning

Machine Learning


  • McGrath, J., Saha, S., Chant, D. & Welham, J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol. Rev. 30, 67–76 (2008).

    PubMed 

    Google Scholar 

  • van Os, J. & Kapur, S. Schizophrenia. Lancet 374, 635–645 (2009).

    PubMed 

    Google Scholar 

  • Kelly, D. L., Conley, R. R. & Carpenter, W. T. First-episode schizophrenia: a focus on pharmacological treatment and safety considerations. Drugs 65, 1113–1138 (2005).

    CAS 
    PubMed 

    Google Scholar 

  • Koutsouleris, N. et al. Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach. Lancet Psychiatry 3, 935–946 (2016).

    PubMed 

    Google Scholar 

  • Yin, Y., et al. Short-term antipsychotic treatment response in early-onset, typical-onset, and late-onset first episode schizophrenia. Schizophr. Res. 257, 58–63 (2023).

    CAS 
    PubMed 

    Google Scholar 

  • Tsang, H. W. H., Leung, A. Y., Chung, R. C. K., Bell, M. & Cheung, W.-M. Review on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998. Aust. N. Z. J. Psychiatry 44, 495–504 (2010).

    PubMed 

    Google Scholar 

  • Tay, J. L., Htun, K. K. & Sim, K. Prediction of Clinical Outcomes in Psychotic Disorders Using Artificial Intelligence Methods: A Scoping Review. Brain Sci. 14, 878 (2024).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Guo, L.-K., et al. Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis. Mil. Med Res. 10, 24 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Çetin, M. S. et al. Thalamus and posterior temporal lobe show greater inter-network connectivity at rest and across sensory paradigms in schizophrenia. Neuroimage 97, 117–126 (2014).

    PubMed 

    Google Scholar 

  • Kraguljac, N. V. et al. Neuroimaging Biomarkers in Schizophrenia. Am. J. Psychiatry 178, 509–521 (2021).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Ayesa-Arriola, R. et al. Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients. Eur. Arch. Psychiatry Clin. Neurosci. 266, 619–628 (2016).

    PubMed 

    Google Scholar 

  • Rodríguez-Sánchez, J. M., et al. Course of cognitive deficits in first episode of non-affective psychosis: a 3-year follow-up study. Schizophr. Res. 150, 121–128 (2013).

    PubMed 

    Google Scholar 

  • Rodríguez-Sánchez, J. M., et al. Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort. Psychol. Med. 52, 770–779 (2022).

    PubMed 

    Google Scholar 

  • Bora, E. Neurodevelopmental origin of cognitive impairment in schizophrenia. Psychol. Med. 45, 1–9 (2015).

    CAS 
    PubMed 

    Google Scholar 

  • Owen, M. J., O’Donovan, M. C., Thapar, A. & Craddock, N. Neurodevelopmental hypothesis of schizophrenia. Br. J. Psychiatry 198, 173–175 (2011).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Rapoport, J. L., Giedd, J. N. & Gogtay, N. Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry 17, 1228–1238 (2012).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Woodberry, K. A., Giuliano, A. J. & Seidman, L. J. Premorbid IQ in schizophrenia: a meta-analytic review. Am. J. Psychiatry 165, 579–587 (2008).

    PubMed 

    Google Scholar 

  • Cui, H., et al. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes. Schizophr. Res. 226, 138–146 (2020).

    PubMed 

    Google Scholar 

  • Javitt, D. C. Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment. Annu Rev. Pharm. Toxicol. 63, 119–141 (2023).

    CAS 

    Google Scholar 

  • Trampush, J. W. et al. Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders. Schizophr. Bull. 41, 1237–1247 (2015).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Torgalsbøen, A.-K., Mohn, C. & Rishovd Rund, B. Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia. Psychiatry Res. 216, 1–5 (2014).

    PubMed 

    Google Scholar 

  • Zhou, F.-C. et al. Predictive value of prospective memory for remission in first-episode schizophrenia. Perspect. Psychiatr. Care 50, 102–110 (2014).

    PubMed 

    Google Scholar 

  • Graham, S., et al. Artificial Intelligence for Mental Health and Mental Illnesses: an Overview. Curr. Psychiatry Rep. 21, 116 (2019).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Leighton, S. P. et al. Predicting one-year outcome in first episode psychosis using machine learning. PLoS One 14, e0212846 (2019).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • de Nijs, J. et al. Individualized prediction of three- and six-year outcomes of psychosis in a longitudinal multicenter study: a machine learning approach. NPJ Schizophr. 7, 34 (2021).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Fonseka, L. N. & Woo, B. K. P. Wearables in Schizophrenia: Update on Current and Future Clinical Applications. JMIR Mhealth Uhealth 10, e35600 (2022).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Selective Review of Neuroimaging Findings in Youth at Clinical High Risk for Psychosis: On the Path to Biomarkers for Conversion – PubMed. https://pubmed.ncbi.nlm.nih.gov/33173516/.

  • Blake, K. V., et al. Advanced brain ageing in adult psychopathology: A systematic review and meta-analysis of structural MRI studies. J. Psychiatr. Res. 157, 180–191 (2023).

    PubMed 

    Google Scholar 

  • Yee, J. Y. et al. Predicting antipsychotic responsiveness using a machine learning classifier trained on plasma levels of inflammatory markers in schizophrenia. Transl. Psychiatry 15, 51 (2025).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Jeon, S. M., Cho, J., Lee, D. Y. & Kwon, J.-W. Comparison of prediction methods for treatment continuation of antipsychotics in children and adolescents with schizophrenia. Evid. Based Ment. Health 25, e26–e33 (2022).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Han, X. et al. The Chinese First-Episode Schizophrenia. Trial.: Backgr. study Des. East Asian Arch. Psychiatry 24, 169–173 (2014).

    CAS 

    Google Scholar 

  • Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261–276 (1987).

    CAS 
    PubMed 

    Google Scholar 

  • Tianmei, S., et al. The Chinese version of the Personal and Social Performance Scale (PSP): validity and reliability. Psychiatry Res. 185, 275–279 (2011).

    PubMed 

    Google Scholar 

  • Yu, X. MCCB China Norm Manual. (Peking University Medical Press, 2014).

  • Shi, C. et al. The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China. Schizophrenia Res. 169, 109–115 (2015).

    Google Scholar 

  • Fong, T. C. T., Ho, R. T. H., Wan, A. H. Y., Siu, P. J. C. Y. & Au-Yeung, F. S. W. Psychometric validation of the consensus five-factor model of the Positive and Negative Syndrome Scale. Compr. Psychiatry 62, 204–208 (2015).

    PubMed 

    Google Scholar 

  • Zhang, H. et al. Meta-analysis of cognitive function in Chinese first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment. Gen. Psychiatr. 32, e100043 (2019).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Chen, Y.-W. & Lin, C.-J. Combining SVMs with Various Feature Selection Strategies. in Feature Extraction: Foundations and Applications (eds. Guyon, I., Nikravesh, M., Gunn, S. & Zadeh, L. A.) 315–324 (Springer, Berlin, Heidelberg, 2006). https://doi.org/10.1007/978-3-540-35488-8_13.

  • Ojeda, N., Peña, J., Sánchez, P., Elizagárate, E. & Ezcurra, J. Processing speed mediates the relationship between verbal memory, verbal fluency, and functional outcome in chronic schizophrenia. Schizophr. Res. 101, 225–233 (2008).

    PubMed 

    Google Scholar 

  • Ojeda, N., et al. Hierarchical structure of the cognitive processes in schizophrenia: the fundamental role of processing speed. Schizophr. Res. 135, 72–78 (2012).

    CAS 
    PubMed 

    Google Scholar 

  • Lucas, S. K., Redoblado-Hodge, M. A., Shores, E. A., Brennan, J. & Harris, A. Factors associated with functional psychosocial status in first-episode psychosis. Early Inter. Psychiatry 3, 35–43 (2009).

    Google Scholar 

  • Sánchez, P. et al. Predictors of longitudinal changes in schizophrenia: the role of processing speed. J. Clin. Psychiatry 70, 888–896 (2009).

    PubMed 

    Google Scholar 

  • Li, J. et al. The dynamic process of hyperfocusing and hyperfiltering in schizophrenia. Nat. Ment. Health 2, 367–378 (2024).

    Google Scholar 

  • Peña, J., et al. Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study. J. Psychiatr. Res. 46, 774–781 (2012).

    PubMed 

    Google Scholar 

  • Benoit, A., et al. Changes in memory performance over a 12-month period in relation to achieving symptomatic remission after a first-episode psychosis. Schizophr. Res. 153, 103–108 (2014).

    PubMed 

    Google Scholar 

  • Becker, H. E., et al. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration? Psychol. Med. 40, 1599–1606 (2010).

    CAS 
    PubMed 

    Google Scholar 

  • Tschentscher, N. et al. Neurocognitive Deficits in First-Episode and Chronic Psychotic Disorders: A Systematic Review from 2009 to 2022. Brain Sci 13, 299 (2023).

  • Bora, E., Yalincetin, B., Akdede, B. B. & Alptekin, K. Duration of untreated psychosis and neurocognition in first-episode psychosis: A meta-analysis. Schizophr. Res 193, 3–10 (2018).

    PubMed 

    Google Scholar 

  • Gschwandtner, U. et al. Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 256, 201–206 (2006).

    PubMed 

    Google Scholar 

  • Gebreegziabhere, Y., Habatmu, K., Mihretu, A., Cella, M. & Alem, A. Cognitive impairment in people with schizophrenia: an umbrella review. Eur. Arch. Psychiatry Clin. Neurosci. 272, 1139–1155 (2022).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Lee, M. et al. Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis: A Systematic Review and Meta-Analysis. JAMA Psychiatry 81, 468–476 (2024).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Alfimova, M. V. et al. Facial affect recognition deficit as a marker of genetic vulnerability to schizophrenia. Span. J. Psychol. 12, 46–55 (2009).

    PubMed 

    Google Scholar 

  • Leppänen, J. M., et al. Deficits in facial affect recognition in unaffected siblings of Xhosa schizophrenia patients: evidence for a neurocognitive endophenotype. Schizophr. Res. 99, 270–273 (2008).

    PubMed 

    Google Scholar 

  • Kee, K. S., Horan, W. P., Mintz, J. & Green, M. F. Do the siblings of schizophrenia patients demonstrate affect perception deficits? Schizophr. Res. 67, 87–94 (2004).

    PubMed 

    Google Scholar 

  • Gur, R. E. et al. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am. J. Psychiatry 164, 813–819 (2007).

    PubMed 

    Google Scholar 

  • Hirjak, D., et al. Motor dysfunction within the schizophrenia-spectrum: A dimensional step towards an underappreciated domain. Schizophr. Res. 169, 217–233 (2015).

    PubMed 

    Google Scholar 

  • Tsapakis, E.-M., Mitkani, C. A. & Fountoulakis, K. N. Neurological soft signs and schizophrenia. CNS Spectr. 28, 657–661 (2023).

    PubMed 

    Google Scholar 

  • Tolle, K. A., Rahman-Filipiak, A. M., Hale, A. C., Kitchen Andren, K. A. & Spencer, R. J. Grooved Pegboard Test as a measure of executive functioning. Appl Neuropsychol. Adult 27, 414–420 (2020).

    PubMed 

    Google Scholar 

  • Blessing, E. M. et al. Anterior Hippocampal-Cortical Functional Connectivity Distinguishes Antipsychotic Naïve First-Episode Psychosis Patients From Controls and May Predict Response to Second-Generation Antipsychotic Treatment. Schizophr. Bull. 46, 680–689 (2020).

    PubMed 

    Google Scholar 

  • Linke, M., et al. Age or age at onset? Which of them really matters for neuro and social cognition in schizophrenia? Psychiatry Res. 225, 197–201 (2015).

    PubMed 

    Google Scholar 

  • Yin, Y. et al. The age of onset and cognitive impairment at the early stage of schizophrenia. Cogn. Neurodyn 17, 183–190 (2023).

    PubMed 

    Google Scholar 

  • Whitty, P., et al. Predictors of outcome in first-episode schizophrenia over the first 4 years of illness. Psychol. Med. 38, 1141–1146 (2008).

    CAS 
    PubMed 

    Google Scholar 

  • Perkins, D. et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br. J. Psychiatry 185, 18–24 (2004).

    PubMed 

    Google Scholar 

  • Flechsenhar, A., Kanske, P., Krach, S., Korn, C. & Bertsch, K. The (un)learning of social functions and its significance for mental health. Clin. Psychol. Rev. 98, 102204 (2022).

    PubMed 

    Google Scholar 

  • Farooq, S. et al. Development and initial evaluation of a clinical prediction model for risk of treatment resistance in first-episode psychosis: Schizophrenia Prediction of Resistance to Treatment (SPIRIT). Br. J. Psychiatry 225, 379–388 (2024).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Del Fabro, L. et al. Machine learning methods to predict outcomes of pharmacological treatment in psychosis. Transl. Psychiatry 13, 75 (2023).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Chekroud, A. M. et al. The promise of machine learning in predicting treatment outcomes in psychiatry. World Psychiatry 20, 154–170 (2021).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Fusar-Poli, P., Hijazi, Z., Stahl, D. & Steyerberg, E. W. The Science of Prognosis in Psychiatry: A Review. JAMA Psychiatry 75, 1289–1297 (2018).

    PubMed 

    Google Scholar 

  • Sharma, H., Harsora, H. & Ogunleye, B. An Optimal House Price Prediction Algorithm: XGBoost. Analytics 3, 30–45 (2024).

    Google Scholar 

  • McCutcheon, R. A., Keefe, R. S. E. & McGuire, P. K. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol. Psychiatry 28, 1902–1918 (2023).

    PubMed 
    PubMed Central 

    Google Scholar 

  • Fett, A.-K. J. et al. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci. Biobehav Rev. 35, 573–588 (2011).

    PubMed 

    Google Scholar 

  • Green, M. F., Horan, W. P. & Lee, J. Social cognition in schizophrenia. Nat. Rev. Neurosci. 16, 620–631 (2015).

    CAS 
    PubMed 

    Google Scholar 



  • Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *